These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16474166)

  • 1. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
    Chakraborty G; Rangaswami H; Jain S; Kundu GC
    J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
    Mahabeleshwar GH; Das R; Kundu GC
    J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.
    Walk SF; March ME; Ravichandran KS
    Eur J Immunol; 1998 Aug; 28(8):2265-75. PubMed ID: 9710204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
    Chen XL; Li L; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes.
    Jiang Y; Cheng H
    Leuk Res; 2007 Apr; 31(4):541-5. PubMed ID: 16938345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.
    Trisciuoglio D; Iervolino A; Candiloro A; Fibbi G; Fanciulli M; Zangemeister-Wittke U; Zupi G; Del Bufalo D
    J Biol Chem; 2004 Feb; 279(8):6737-45. PubMed ID: 14660675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis.
    Mishra R; Thorat D; Soundararajan G; Pradhan SJ; Chakraborty G; Lohite K; Karnik S; Kundu GC
    Oncogene; 2015 Mar; 34(12):1584-95. PubMed ID: 24727891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.
    Zhang X; Shrikhande U; Alicie BM; Zhou Q; Geahlen RL
    Mol Cancer Res; 2009 May; 7(5):634-44. PubMed ID: 19435818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
    Li J; Sidell N
    Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk.
    Williams S; Couture C; Gilman J; Jascur T; Deckert M; Altman A; Mustelin T
    Eur J Biochem; 1997 Apr; 245(1):84-90. PubMed ID: 9128727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Syk protein tyrosine kinase can function independently of CD45 or Lck in T cell antigen receptor signaling.
    Chu DH; Spits H; Peyron JF; Rowley RB; Bolen JB; Weiss A
    EMBO J; 1996 Nov; 15(22):6251-61. PubMed ID: 8947048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.